Lauren P. Silvernail
Chief Financial Officer, ISTA PHARMACEUTICALS INC.
Companies
- DYNAVAX TECHNOLOGIES CORPBoard member Feb 5, 2025 to now1
- Harrow HealthBoard member Jan 30, 2024 to now2
- Harpoon Therapeutics, Inc.Board member Sep 19, 2022 to Mar 11, 20243
- Evolus, Inc.Officer May 31, 2018 to May 18, 20224
- Revance Therapeutics, Inc.Chief financial officer Feb 5, 2014 to May 24, 20185
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Evolus, Inc. EOLS141,571 shares6$1.0M at $7.23May 18, 2022
- Harrow Health HROW1,000 shares7$28.1K at $28.14May 18, 2026
- DYNAVAX TECHNOLOGIES CORP0 shares8Feb 10, 2026
- Harpoon Therapeutics, Inc.0 shares9Mar 11, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- May 18, 2026Bought 1,000 shares at $31.00 of Harrow Health7
- Feb 10, 2026Returned to company 10,075 shares of DYNAVAX TECHNOLOGIES CORP8
- Jun 11, 2025Granted 1,439 shares of DYNAVAX TECHNOLOGIES CORP10
- Mar 11, 2024Returned to company 5,000 shares of Harpoon Therapeutics, Inc.9
- Nov 27, 2023Granted 5,000 shares of Harpoon Therapeutics, Inc.11
- May 18, 2022Sold 52,015 shares at $12.42 of Evolus, Inc.6
- May 17, 2022Sold 16,189 shares at $13.92 of Evolus, Inc.6
- Mar 8, 2022Sold 10,192 shares at $9.73 of Evolus, Inc.12
- Jan 24, 2022Granted 53,571 shares of Evolus, Inc.13
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARHarrow Health, Board member
- 3
- 4SEC EDGAREvolus, Inc., Officer
- 5
- 6
- 7
- 8
- 9
- 10SEC EDGARForm 4 filed Jun 13, 2025
- 11SEC EDGARForm 4 filed Nov 28, 2023
- 12SEC EDGARForm 4 filed Mar 10, 2022
- 13SEC EDGARForm 4 filed Jan 26, 2022